Clik here to view.
Pacific Prime Launches the State of Health Insurance Report 2021-2022
HONG KONG Pacific Prime, an award-winning global health insurance brokerage and employee benefits specialist, has released the fifth edition of their annual State of Health Insurance Report. This...
View ArticleClik here to view.
Clik here to view.
奖金高达25万美元的2023年Aster守护者全球护理奖现面向全球护士开放申请
阿联酋迪拜 (美国商业资讯)–为持续表彰护士对人类和医疗保健界的贡献，Aster DM Healthcare宣布筹办新一届Aster守护者全球护理奖(Aster Guardian Global Nursing...
View ArticleClik here to view.
GenBody America Receives Amendment to FDA Emergency Use Authorization for...
JURUPA VALLEY, Calif. GenBody America, LLC, the U.S. affiliate of GenBody, Inc., a South Korean manufacturer of rapid diagnostic tests and reagents for point-of-care applications for COVID-19, today...
View ArticleClik here to view.
Clik here to view.
InnoCare Announces Priority Review of Orelabrutinib for the Treatment of R/R...
BEIJING InnoCare Pharma (HKEX: 09969), a leading biopharmaceutical company for the treatment of cancer and autoimmune diseases, announced today that BTK inhibitor orelabrutinib has been granted...
View ArticleClik here to view.
SINOVAC Approved to Initiate Clinical Trial for Its Omicron Containing...
BEIJING Sinovac Biotech Ltd. (“SINOVAC” or the “Company”) (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, announced that the Chilean Public Health Institute (Instituto de...
View ArticleClik here to view.
Kirin Holdings: Spoon and Bowl That Enhance the Salty Taste of Low-sodium...
TOKYO Kirin Holdings Company, Limited (Kirin) and the Meiji University Dr. Homei Miyashita Laboratory of the Department of Frontier Media Science, School of Interdisciplinary Mathematical Sciences...
View ArticleClik here to view.
Fresenius Medical Care partners with National Kidney Foundation Malaysia in...
HONG KONG Fresenius Medical Care, the world’s leading provider of products and services for individuals with renal diseases, today signed a memorandum of understanding (MoU) with the National Kidney...
View ArticleClik here to view.
科兴获准在智利启动可预防奥米克戎的新冠疫苗临床试验
北京 (美国商业资讯)–中国领先的生物制品供应商科兴控股生物技术有限公司（简称“SINOVAC”或“公司”）(NASDAQ: SVA)宣布，智利公共卫生研究院(Instituto de Salud Pública,...
View ArticleClik here to view.
シノバックのオミクロン株を含むCOVID-19ワクチンの臨床試験の開始がチリで承認される
北京 （ビジネスワイヤ） — 中国でバイオ医薬品を提供する一流企業であるシノバック・バイオテック（「シノバック」または「当社」）（NASDAQ: SVA）は、チリ公衆衛生研究所（Instituto de Salud...
View ArticleClik here to view.
Azura Ophthalmics Secures Grant to Evaluate AZR-MD-001 for Improved Vision...
TEL AVIV, Israel & MELBOURNE, Australia Azura Ophthalmics Ltd. (Azura), a clinical-stage biopharmaceutical company developing a new therapeutic class of Ophthalmic Keratolytics for ocular...
View ArticleClik here to view.
Genexine’s First-in-Class Therapeutic DNA Vaccine Shows Significant Potential...
SEOUL, South Korea Genexine (KOSDAQ: 095700), a publicly traded, clinical-stage Korean biopharmaceutical company committed to the discovery and development of novel biologics for the treatment of...
View ArticleClik here to view.
麒麟控股株式会社：电子勺碗通过刺激可使低钠食物的咸味提升约1.5倍*1
东京 (美国商业资讯)–麒麟控股株式会社（Kirin Holdings Company, Limited，简称“麒麟控股”）与明治大学(Meiji University)跨学科数学科学学院前沿媒体科学系Homei...
View ArticleClik here to view.
PHC株式会社：マンション居住者を対象としたオンライン健康相談プログラム実証実験を開始～リアルタイム遠隔医療システム「Teladoc...
東京 （ビジネスワイヤ） — PHC株式会社（以下、「PHC」）、株式会社メディロム（以下、「メディロム」）、三菱地所株式会社（以下、「三菱地所」）、株式会社Confie（以下、「Confie」）、TaqTik Health Inc. （以下、「TaqTik...
View ArticleClik here to view.
Rhizen Pharmaceuticals...
スイス・バーゼル （ビジネスワイヤ） — スイスに拠点を置く非公開の臨床段階バイオ製薬企業であるRhizen Pharmaceuticals AG（Rhizen）は本日、2022年9月9～13日にパリで開催予定のESMO 2022において、局所進行性／転移性乳がんを対象に進行中のテナリシブの第2相試験のデータおよび完了したRP12146の用量漸増相試験のデータを報告すると発表しました。...
View ArticleClik here to view.
CANbridge Pharmaceuticals to Participate in Two Investor Conferences in...
BEIJING & CAMBRIDGE, Mass. CANbridge Pharmaceuticals, Inc. (HKEX:1228) , a China and U.S.-based global biopharmaceutical company committed to the research, development and commercialization of...
View ArticleClik here to view.
Rhizen Pharmaceuticals AG宣布即将在ESMO...
瑞士巴塞尔 (美国商业资讯)–总部位于瑞士的私营临床阶段生物制药公司Rhizen Pharmaceuticals AG (Rhizen)今天宣布，于2022年9月9日至13日在巴黎举行的2022年欧洲肿瘤内科学会年会(ESMO 2022)上展示正在进行的Tenalisib治疗局部晚期或转移性乳腺癌的II期试验数据，以及RP12146的剂量递增阶段的结论数据。...
View ArticleClik here to view.
Takeda Selects New Partners for Global Corporate Social Responsibility (CSR)...
OSAKA, Japan Takeda (TSE:4502/NYSE:TAK) today announced four new partnerships to its Global Corporate Social Responsibility (CSR) Program, which makes long-term commitments to strengthen healthcare...
View ArticleClik here to view.
Olympus Launches VISERA ELITE III Surgical Visualization Platform
TOKYO Olympus Corporation (“Olympus” – Director, Representative Executive Officer, President and CEO: Yasuo Takeuchi) today announced the launch of VISERA ELITE III, its newest surgical...
View Article